Clinical Trials Browser

Completed × OTHER × Interventional × Clear all

NCT01057953 2026-04-16

DOCC

Phase NA Completed

Gastrointestinal

Colonic Neoplasms, Neoplasms

NCT01857934 2026-04-16

Therapy for Children With Advanced Stage Neuroblastoma

Phase 2 Completed

153 enrolled 12 charts

Neuroblastoma

NCT01931579 2026-04-16

NODIVEM

Phase NA Completed

Respiratory Tract Neoplasms

NCT02110329 2026-04-16

Code Barre

Phase NA Completed

Gastrointestinal

Colorectal Neoplasms

NCT02557061 2026-04-16

TIL

Phase NA Completed

Gastrointestinal

Colorectal Neoplasms

NCT02816697 2026-04-16

Implementation of a System-level Tobacco Treatment Intervention

Phase NA Completed

Lung Neoplasms, Smoking, Smoking Cessation

NCT02872779 2026-04-16

COCA-MACS

Phase NA Completed

Gastrointestinal

Colorectal Neoplasms

NCT03574792 2026-04-16

Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy

Phase 2 Completed

62 enrolled 10 charts

DermatologicHead & Neck

Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8

NCT03634241 2026-04-16

Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study

Phase 2 Completed

45 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04085276 2026-04-16

TORCHLIGHT

Phase 3 Completed

Triple Negative Breast Neoplasms

NCT04355156 2026-04-16

AXMUS-C

Phase 2 Completed

52 enrolled 12 charts

Gastrointestinal

Colorectal Neoplasms

NCT04392960 2026-04-16

Novel Imaging Tools in Newly-diagnosed Patients With Cardiac AL Amyloidosis

Phase NA Completed

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT04479306 2026-04-16

Osimertinib in Combination With Alisertib or Sapanisertib for the Treatment of Osimertinib-Resistant EGFR Mutant Stage IIIB or IV Non-Small Cell Lung Cancer

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06418750 2026-04-16

DELICATESSE

Phase NA Completed

Multiple Myeloma

NCT06464965 2026-04-16

Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer

Phase 1 Completed

Gastrointestinal

Stomach Neoplasms

NCT07532057 2026-04-16

PR-LUNGCA-2019

Phase NA Completed

Lung Neoplasms, Neoplasms, Small Cell Lung Carcinoma

NCT07532707 2026-04-16

Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria.

Phase NA Completed

Myasthenia Gravis

NCT07534631 2026-04-16

Holmium Laser En-Bloc Resection Versus Conventional Transurethral Resection of Bladder Tumors for Treatment of Non-muscle- Invasive Bladder Cancer

Phase NA Completed

Urinary Bladder Neoplasms

NCT00814021 2026-04-15

Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain

Phase 2 Completed

CNSGenitourinary

Brain Neoplasms, Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Metastasis

NCT01384513 2026-04-15

A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies

Phase 2 Completed

40 enrolled 15 charts

Classical hematologyDermatologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Anemia, Aplastic, Anemia, Refractory, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Mastocytosis, Multiple Myeloma, Mycosis Fungoides, Myeloproliferative Disorders, Polycythemia Vera, Recurrence, Sezary Syndrome, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Leukemia, Myelomonocytic, Juvenile, Primary Myelofibrosis

NCT01868087 2026-04-15

Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study

Phase EARLY_PHASE1 Completed

Urinary Bladder Neoplasms

NCT02143219 2026-04-15

PAMELA70

Phase 2 Completed

72 enrolled 7 charts

Gastrointestinal

Pancreatic Metastatic Cancer

NCT02379520 2026-04-15

HESTIA

Phase 1 Completed

Neoplasms, Recurrence

NCT03030248 2026-04-15

Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients

Phase 2 Completed

9 enrolled 9 charts

Clostridium Infections, Hematologic Diseases

NCT03451799 2026-04-15

Ketogenic Diet in Combination With Standard-of-care Radiation and Temozolomide for Patients With Glioblastoma

Phase 1 Completed

Glioblastoma

NCT03935282 2026-04-15

AH-HA

Phase NA Completed

645 enrolled 43 charts

BreastGastrointestinalGenitourinaryGynecologicLymphoid

Breast Neoplasms, Cardiovascular Diseases, Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Health Behavior, Endometrial Neoplasms

NCT04028245 2026-04-15

SPARC-1

Phase EARLY_PHASE1 Completed

Carcinoma, Renal Cell

NCT04449315 2026-04-15

Outpatient Oncology Aromatherapy for Symptom Management

Phase NA Completed

Anxiety Disorders, Nausea

NCT05247164 2026-04-15

EUPhORIC

Phase NA Completed

Gastrointestinal

Neoplastic Cells, Circulating, Pancreatic Neoplasms

NCT05489978 2026-04-15

Effectiveness of a Cervical Cancer Stigma Reduction Intervention Program on Cancer Stigma Score and Cervical Cancer Screening Uptake in Nepal

Phase NA Completed

Uterine Cervical Neoplasms, Social Stigma

NCT05925166 2026-04-15

Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ Fusion Protein in the Treatment of Acute Gout

Phase NA Completed

Acute Gout

NCT07530952 2026-04-15

VR&depression

Phase NA Completed

Depression, Lymphoma, Follicular

NCT00083135 2026-04-14

N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation

Phase 1 Completed

Neuroblastoma

NCT00093353 2026-04-14

N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma

Phase 1 Completed

Diarrhea, Neuroblastoma, Drug-Related Side Effects and Adverse Reactions

NCT00295919 2026-04-14

N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma

Phase 1 Completed

Neuroblastoma

NCT00509353 2026-04-14

N2004-06: Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk Neuroblastoma

Phase 1 Completed

Neuroblastoma

NCT00646230 2026-04-14

IV Fenretinide

Phase 1 Completed

Neuroblastoma

NCT00864318 2026-04-14

TICE

Phase 2 Completed

Neoplasms, Germ Cell and Embryonal, Recurrence

NCT01118676 2026-04-14

Cilengitide Together With Radiochemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung

NCT01127295 2026-04-14

PHACS

Phase 4 Completed

Breast Neoplasms

NCT01553903 2026-04-14

OXYTAM

Phase 4 Completed

Breast Neoplasms

NCT01612871 2026-04-14

MIRHO

Phase 4 Completed

Breast Neoplasms

NCT01872221 2026-04-14

STEMRI

Phase NA Completed

Glioblastoma

NCT01902680 2026-04-14

CURIEFOCALE

Phase 2 Completed

Prostatic Neoplasms

NCT02203643 2026-04-14

FORTE

Phase 2 Completed

Multiple Myeloma

NCT02311959 2026-04-14

MAPAM-01

Phase 3 Completed

Breast Neoplasms, Carcinoma in Situ

NCT02854215 2026-04-14

CURSOC

Phase NA Completed

Ovarian Neoplasms

NCT02857400 2026-04-14

CREDO

Phase NA Completed

Neoplasm Metastasis

NCT02866747 2026-04-14

STERIMGLI

Phase 1/2 Completed

Glioblastoma

NCT03348891 2026-04-14

MELANFα

Phase NA Completed

Melanoma